Lifeline Scientific announces $1,500,000 working capital facility
17 August 2009
LifePort Recognised as Key Medical Device
12 August 2009 – Lifeline Scientific, the medical technology company focused on commercialising its LifePort® Kidney
Transporter, an advanced organ preservation and transport system, designed to address the global challenge of human donor organ shortages, announces that Medical Device & Diagnostic Industry ("MDDI") magazine has recognised the LifePort® Kidney Transporter as one of the top medical devices of the past 30 years.
Block Listing Six Monthly Return
11 August 2009
Trial Results Published at American Transplant Congress
18 June 2009 – Data from non-heart beating donors and donors over 65 further underline clear advantagesof machine perfusion over traditional ice box storage for kidney transplant
Study demonstrates long-term cost effectiveness of machine perfusion versus static cold storage
Further Results from Machine Preservation Trial
20 August 2008 – LifePort Kidney Transporter demonstrates clear advantages over traditional ice box storage for kidney transplants
Lifeline Scientific New Contract Wins
9 June 2008 – Lifeline division wins contracts to supply LifePort Kidney Transporters to largest Canadian transplant programmes.
Lifeline sScientific announces AGM notice and
document availability
14 May 2008
Lifeline Scientific posts preliminary results for
the year ended 31 December 2007
13 May 2008 – Lifeline announces its first
set of preliminary results since its flotation on
the AIM Market of the London Stock Exchange and
commencement of trading in January 2008.
Lifeline Scientific announces block listings
12 May 2008 – Lifeline announces that an
application has been made to the London Stock
Exchange for the admission to trading on AIM of a
block listing of 2,947,803 common shares of US $0.01
each.
Lifeline Scientific division wins contracts
10 March 2008 — Organ Recovery Systems, a
division of Lifeline Scientific wins contracts to
supply two leading transplant centers with the LifePort® Kidney Transporter.
Lifeline Scientific announces successful completion
of IPO
7 January 2008 — Lifeline announces the successful completion of its flotation on the AIM Market of the London Stock Exchange. The Company raised a total of £5.4 million from the placing of new common shares with institutional and other investors at a price of 150p per share.
Lifeline Scientific announces proposed AIM flotation and placing
17 September 2007 — Addressing the global problem of human donor organ shortage. Lifeline today announces its attention to seek admission to AIM with an institutional placing to raise approximately £7 million.
